
Mozobil Coupons & Discount Card - Compare Prices Near You
plerixafor
My prescription
Edit
1.2ML of 24MG/1.2ML, Plerixafor (1 Vial)
Select pharmacy

Walgreens
$154.00
COUPON PRICE
Albertsons
$338.45
COUPON PRICE
Rite Aid
$421.01
COUPON PRICEMozobil savings card
Show this card to your pharmacist
Walgreens
$154.00
BIN
ID
PCN
GRP
019876
LH743EC575
CHIPPO
LHX
Powered by
Related immune response modifiers prescriptions
More prescriptions for multiple myeloma
Related immune response modifiers prescriptions
More prescriptions for multiple myeloma
Mozobil dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
1.2ML of 24MG/1.2ML | 1 Vial | $154 | $154 |
Mozobil Warnings
When using Mozobil (plerixafor), it is crucial to be aware of certain safety information and warnings to ensure safe and effective treatment. Please carefully consider the following points and consult with your healthcare provider if you have any questions or concerns:
Severe Allergic Reactions: Mozobil (plerixafor) can, in rare instances, trigger serious allergic reactions, including anaphylaxis. Healthcare providers will monitor patients during administration and for at least 30 minutes afterward to detect any adverse reactions. Seek immediate medical attention if you experience symptoms such as rash, difficulty breathing, dizziness, or swelling of the lips, tongue, or throat.
Blood Monitoring: Treatment with Mozobil (plerixafor) alongside G-CSF may lead to alterations in blood cell counts, such as increased white blood cells and decreased platelets. Regular blood tests will be conducted to ensure blood cell counts remain within a safe range.
Spleen Enlargement: Some individuals receiving Mozobil (plerixafor) with G-CSF have developed an enlarged spleen, which can, in severe cases, lead to spleen rupture—a potentially fatal condition. Report any pain felt in the upper left abdomen or shoulder to your healthcare provider immediately.
Use During Pregnancy: Animal studies indicate that Mozobil (plerixafor) may harm an unborn baby if used during pregnancy. It is advised to use effective birth control while on Mozobil (plerixafor) treatment and for one week after the last dose to prevent pregnancy. This medication is not recommended for use during pregnancy or breastfeeding.
There are no specific contraindications listed for Mozobil (plerixafor) at this time. Always discuss your medical history and any concerns with your healthcare provider before starting treatment.
Mozobil Side Effects
When taking this medication, some individuals may experience common side effects such as diarrhea, nausea, vomiting, and gas. You might also notice reactions at the injection site, including redness, swelling, or pain. Additionally, some people feel tired, have headaches, or encounter joint pain. Dizziness and trouble sleeping are less common, yet possible. These effects are generally mild, but if they persist or worsen, it is advisable to consult with a healthcare provider for guidance.
There are other side effects that have been reported, including muscle and bone pain, stomach pain, constipation, bloating, dry mouth, mouth numbness, and excessive sweating. While these are less common, it's important to be aware of them and discuss any concerns with a healthcare professional.
Serious side effects, although rare, demand immediate medical attention. These include severe allergic reactions characterized by rash, trouble breathing, or swelling of the lips, tongue, or throat. Another serious condition is a ruptured spleen, which can present as pain in the left upper abdomen or shoulder. If you experience any of these severe symptoms, seek urgent medical care.
It's essential to monitor your body's response to the medication and communicate any unusual or severe symptoms to a healthcare provider to ensure your safety and well-being.
What is Mozobil used for?
Mozobil is used to mobilize hematopoietic stem cells in patients with certain types of cancers, such as non-Hodgkin's lymphoma and multiple myeloma, to prepare them for collection and subsequent autologous stem cell transplantation.
What class of drug is plerixafor?
Plerixafor is classified as a hematopoietic stem cell mobilizer.
Is plerixafor FDA approved?
Yes, plerixafor is FDA approved. It is used in combination with a granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.
Is plerixafor hazardous?
Plerixafor can be hazardous if not used properly. It is a medication that should be administered under the supervision of a healthcare professional. Potential side effects include nausea, diarrhea, injection site reactions, and dizziness. It is important for patients to discuss their medical history and any other medications they are taking with their healthcare provider to ensure safe use.
How does Mozobil work?
Mozobil works by mobilizing hematopoietic stem cells from the bone marrow into the bloodstream. It is used in combination with a granulocyte-colony stimulating factor (G-CSF) to enhance the collection of stem cells for transplantation. Mozobil inhibits the CXCR4 chemokine receptor, which disrupts the interaction between stem cells and the bone marrow, allowing the cells to move into the peripheral blood where they can be collected more easily.